文献速递免疫规划卫生政策与健康促进

《平价医疗法案》与美国人类乳头瘤病毒(HPV)疫苗接种率的变化

The Affordable Care Act and change in human papillomavirus (HPV) vaccine uptake in the United States.
PubMed 文献 · Vaccine · 2025-02-05

研究分析2011至2017年美国国家健康访谈调查中29,216名18-26岁成人数据,评估《平价医疗法案》(ACA)实施前后HPV疫苗接种及接种有利因素的变化。结果显示ACA后接种一剂HPV疫苗的比例上升43%(3.9%至5.5%;OR 1.45,95%CI 1.24,1.70;p<.001),完成至少2剂的比例从12.5%升至17.8%(OR 1.62,95%CI 1.47,1.79),未保险率显著下降,定期就诊率从53.1%升至57.1%(OR 1.17,95%CI 1.09,1.25;p<.001)。

要点

  • ACA后接种一剂HPV疫苗比例上升43%(3.9%至5.5%;OR 1.45,95%CI 1.24,1.70;p<.001)。
  • ACA后完成至少2剂HPV疫苗比例从12.5%升至17.8%(OR 1.62,95%CI 1.47,1.79)。
  • ACA后未保险率显著下降,定期就诊率从53.1%升至57.1%(OR 1.17,95%CI 1.09,1.25;p<.001)。

核心结论

  • ACA与HPV疫苗接种率上升相关,尤其在种族/族裔少数群体中,这一增长可能由未保险率下降和医生就诊可及性增加等接种有利因素驱动。

研究设计与样本

  • 研究分析2011至2017年美国国家健康访谈调查中29,216名18-26岁成人的数据,采用逻辑回归模型评估ACA前(2011-2013年;n=13,494)至ACA后(2014-2017年;n=15,722)接种有利因素和HPV疫苗接种状态的变化,模型调整了贫困、教育、婚姻状况、合并症、性别和地理因素。

主要发现

  • ACA后报告接种一剂HPV疫苗的比例增加43%(3.9%至5.5%;OR 1.45,95%CI 1.24,1.70;p<.001),非西班牙裔白人(OR 1.55,95%CI 1.24,1.94)和黑人(OR 1.59,95%CI 1.12,2.29)中增幅显著。
  • 完成至少2剂HPV疫苗的比例从12.5%升至17.8%(OR 1.62,95%CI 1.47,1.79),西班牙裔人群中尤为显著(7.6%至14.7%,ORinteraction=1.36,95%CI 1.05,1.77;p=.020)。
  • ACA后未保险率显著下降,私人保险者(OR 1.36,95%CI 1.22,1.52;p<.001)和医疗补助保险者(OR 1.81,95%CI 1.35,2.43;p<.001)中疫苗接种完成比值比增加。
  • 定期医生就诊率从ACA前至ACA后上升(53.1%至57.1%,OR 1.17,95%CI 1.09,1.25;p<.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus (HPV) vaccination uptake has increased in the United States yet continues to fall short of the Healthy People 2030 goal. Cost of care is a known barrier. The Affordable Care Act (ACA) aimed to enhance access to preventive healthcare services, including HPV vaccination. Our study examined the association between the ACA and known vaccination-enabling factors in the United States. METHODS: We analyzed data from 29,216 adults aged 18-26 in the National Health Interview Survey from 2011 to 2017. Changes in vaccination-enabling factors (regular physician visitation and changes in health insurance status) and HPV vaccination status pre- (2011-2013; n = 13,494) to post-ACA (2014-2017; n = 15,722) were assessed using logistic regression models adjusted for poverty, education, marital status, comorbidities, sex, and geography. RESULTS: A total of 13,494 and 15,722 eligible individuals were identified pre- and post-ACA, respectively. Post-ACA, the proportion of individuals reporting receipt of one dose of the HPV vaccine increased by 43 % (3.9 % to 5.5 %; OR 1.45, 95 % CI 1.24, 1.70; p < .001), with significant gains among non-Hispanic White (OR 1.55, 95 % CI 1.24, 1.94) and Black individuals (OR 1.59, 95 % CI 1.12, 2.29). Completion of ≥2 doses rose from 12.5 % to 17.8 % (OR 1.62, 95 % CI 1.47, 1.79), notably among Hispanic individuals (7.6 % to 14.7 %, ORinteraction = 1.36, 95 % CI 1.05, 1.77; p = .020). Post-ACA, there was a significant decrease in uninsured rates and an increase in vaccination completion odds among individuals privately insured (OR 1.36, 95 % CI 1.22, 1.52; p < .001) and those insured by Medicaid (OR 1.81, 95 % CI 1.35, 2.43; p < .001). Regular physician visits also rose pre- to post-ACA (53.1 % to 57.1 %, OR 1.17, 95 % CI 1.09, 1.25; p < .001). CONCLUSION: The ACA has been associated with increased HPV vaccination uptake, especially among racial/ethnic minorities, gains likely driven by an increase in vaccination-enabling factors such as decreased uninsurance and increased access to physician visits.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gao MZ, Awonusi OO, Ramkumar SP, et al. The Affordable Care Act and change in human papillomavirus (HPV) vaccine uptake in the United States. Vaccine. 2025. PMID: 39914253. doi:10.1016/j.vaccine.2025.126842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。